Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset— —Joint poster with Bachem demonstrates superiority of Company’s double-stranded RNA ligases compared to ...
The Net Promoter Score from the customer satisfaction survey conducted in Q1 2024 was 66; in Q2 2024, 62; and in Q3 2024, 59, resulting in a score of 62 for 9M 2024. The company reduced net 475 ...